Search - tctmd.com

Displaying 341 - 360 of 538

Sort: Relevancy | Date

News Daily News

Indoor Smoking Bans' Ability to Cut CVD Suggests Need to Expand Policies

L.A. McKeown

May 09, 2018

Podcast

Quantitative Flow Ratio, Live Cases, and More

May 09, 2018

News Industry News

Bellerophon Reaches Agreement with FDA on Study Design of Phase 2b Trial of INOpulse® for Treatment of Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease

May 08, 2018

News Daily News

Implantable Cardiac Monitor for High-Risk ACS Patients Wins FDA Approval

Michael O'Riordan

May 08, 2018

News Conference News EAS 2018

Unlocking Lp(a): Baseline Levels Matter, but So Too Does Absolute Reduction

Yael L. Maxwell

May 08, 2018

News Conference News EAS 2018

Can Clinicians Really Put a Stop to Atherosclerosis? Experts Explore the How and When of CVD Prevention

Yael L. Maxwell

May 07, 2018

News Daily News

Plaque Dislodgement Less Frequent With Transradial vs Transfemoral PCI

Michael O'Riordan

May 07, 2018

News Industry News

Abott Implements Corrective Action for Heartmate 3 Heart Pump

May 07, 2018

Presentation EAS 2018

Lipoprotein(a), PCSK9 Inhibition and Cardiovascular Risk: Insights from the FOURIER Trial

Presenter: Michelle L. O’Donoghue

May 07, 2018

Presentation EAS 2018

LPA variants, risk of coronary disease, and estimated clinical benefit of lipoprotein(a) lowering therapies: a Mendelian randomization analysis

Presenter: Brian A. Ference

May 07, 2018

News Conference News EAS 2018

Biology in the Back Seat: EAS 2018 Opens With Calls for a Big-Picture Approach to CVD Prevention

Yael L. Maxwell

May 07, 2018

Presentation EAS 2018

Stress, Behavior and Cardiovascular Disease

Presenter: Viola Vaccarino

May 06, 2018

News Daily News

Alirocumab Price Slashed in Deal With Express Scripts

Michael O'Riordan

May 03, 2018

News Daily News

LPA Variants Linked With CHD Events in Statin-Treated Patients

Michael O'Riordan

May 03, 2018

News Conference News SCAI 2018

Coronary Plaques in Psoriasis Patients Change After Treatment With Biologics

L.A. McKeown

May 01, 2018

News Daily News

Women Underrepresented in Pivotal Studies Leading to FDA Drug Approval

Michael O'Riordan

May 01, 2018

News Daily News

Seattle Angina Questionnaire Works Equally Well in Women

Michael O'Riordan

April 30, 2018

News Daily News

FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen

Michael O'Riordan

April 25, 2018

News Daily News

FDA Advisors Take Fresh Look at Celecoxib Safety as PRECISION Aspirin Analysis Unveiled

Michael O'Riordan

April 24, 2018

News Daily News

Remaining Active After MI May Help Stave Off Mortality

Todd Neale

April 23, 2018

Advertisement

Indoor Smoking Bans' Ability to Cut CVD Suggests Need to Expand Policies

Quantitative Flow Ratio, Live Cases, and More

Bellerophon Reaches Agreement with FDA on Study Design of Phase 2b Trial of INOpulse® for Treatment of Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease

Implantable Cardiac Monitor for High-Risk ACS Patients Wins FDA Approval

Unlocking Lp(a): Baseline Levels Matter, but So Too Does Absolute Reduction

Can Clinicians Really Put a Stop to Atherosclerosis? Experts Explore the How and When of CVD Prevention

Plaque Dislodgement Less Frequent With Transradial vs Transfemoral PCI

Abott Implements Corrective Action for Heartmate 3 Heart Pump

Lipoprotein(a), PCSK9 Inhibition and Cardiovascular Risk: Insights from the FOURIER Trial

LPA variants, risk of coronary disease, and estimated clinical benefit of lipoprotein(a) lowering therapies: a Mendelian randomization analysis

Biology in the Back Seat: EAS 2018 Opens With Calls for a Big-Picture Approach to CVD Prevention

Stress, Behavior and Cardiovascular Disease

Alirocumab Price Slashed in Deal With Express Scripts

LPA Variants Linked With CHD Events in Statin-Treated Patients

Coronary Plaques in Psoriasis Patients Change After Treatment With Biologics

Women Underrepresented in Pivotal Studies Leading to FDA Drug Approval

Seattle Angina Questionnaire Works Equally Well in Women

FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen

FDA Advisors Take Fresh Look at Celecoxib Safety as PRECISION Aspirin Analysis Unveiled

Remaining Active After MI May Help Stave Off Mortality

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content